UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 186

Sortiert nach

mGlu2/3 receptor agonist (LY354740) in anxiety

Pharmacology, biochemistry and behavior, 2024-09, Vol.242, p.173826, Article 173826

Schoepp, Darryle D.

2024

Volltextzugriff (PDF)

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Nature medicine, 2007-09, Vol.13 (9), p.1102-1107

2007

Volltextzugriff (PDF)

CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography

Neuropharmacology, 2013-03, Vol.66, p.89-98

2013

Volltextzugriff (PDF)

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)

The Journal of pharmacology and experimental therapeutics, 2008-07, Vol.326 (1), p.209

2008

Volltextzugriff (PDF)

Efficacy and Tolerability of an mGlu2 3 Agonist in the Treatment of Generalized Anxiety Disorder

Neuropsychopharmacology (New York, N.Y.), 2008-06, Vol.33 (7), p.1603-1610

2008

Volltextzugriff (PDF)

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

Nature reviews. Drug discovery, 2005-02, Vol.4 (2), p.131-144

2005

Volltextzugriff (PDF)

Metabotropic glutamate receptors in the control of mood disorders

CNS & neurological disorders drug targets, 2007-04, Vol.6 (2), p.87

2007

Volltextzugriff (PDF)

Where will new neuroscience therapies come from?

Nature reviews. Drug discovery, 2011-10, Vol.10 (10), p.715-716

Schoepp, Darryle D

2011

Volltextzugriff (PDF)

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Neuron (Cambridge, Mass.), 2005-12, Vol.48 (6), p.913-922

2005

Volltextzugriff (PDF)

Translating glutamate: from pathophysiology to treatment

Science translational medicine, 2011-09, Vol.3 (102), p.102mr2

2011

Volltextzugriff (PDF)

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

The Journal of pharmacology and experimental therapeutics, 2001-10, Vol.299 (1), p.12

Schoepp, D D

2001

Volltextzugriff (PDF)

Cortical influences of serotonin and glutamate on layer V pyramidal neurons

Progress in brain research, 2021, Vol.261, p.341-378

2021

Volltextzugriff (PDF)

Metabotropic glutamate receptors, 5 years on

Neuropharmacology, 2017-03, Vol.115, p.1-3

2017

Volltextzugriff (PDF)

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

Psychopharmacologia, 2007-07, Vol.193 (1), p.121-136

2007

Volltextzugriff (PDF)

Alzheimer's disease research and development: a call for a new research roadmap

Annals of the New York Academy of Sciences, 2014-04, Vol.1313 (1), p.1-16

2014

Volltextzugriff (PDF)

Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

Journal of neurochemistry, 2000-09, Vol.75 (3), p.889-907

2000

Volltextzugriff (PDF)

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Psychopharmacology, 2005-04, Vol.179 (1), p.271-283

2005

Volltextzugriff (PDF)

Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2− trifluoroethylsulfonyl)pyrid-3-ylmethylamine

Journal of medicinal chemistry, 2003-07, Vol.46 (15), p.3189-3192

2003

Volltextzugriff (PDF)

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039)

The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.308

2007

Volltextzugriff (PDF)

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

Neuropharmacology, 1999-10, Vol.38 (10), p.1431-1476

1999

Volltextzugriff (PDF)

Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus

Neuropharmacology, 2006-08, Vol.51 (2), p.213-228

2006

Volltextzugriff (PDF)

The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats

Behavioural brain research, 2006-08, Vol.171 (2), p.207-215

2006

Volltextzugriff (PDF)

Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344

The Journal of pharmacology and experimental therapeutics, 2006-02, Vol.316 (2), p.905

2006

Volltextzugriff (PDF)

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

The Journal of pharmacology and experimental therapeutics, 2002-12, Vol.303 (3), p.919

2002

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(186)
Japanisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(129)
Animals
(124)
Biological And Medical Sciences
(96)
Rats
(96)
Pharmacology & Pharmacy
(85)
Male
(71)
Neurosciences
(58)
Neurosciences & Neurology
(58)
Medical Sciences
(53)
Pharmacology. Drug Treatments
(48)
Humans
(47)
Fundamental And Applied Biological Sciences. Psychology
(45)
Neuropharmacology
(44)
Receptors, Metabotropic Glutamate - Agonists
(44)
Rats, Sprague-Dawley
(40)
Neurotransmitters. Neurotransmission. Receptors
(35)
Chemistry, Medicinal
(33)
Excitatory Amino Acid Agonists - Pharmacology
(31)
Glutamatergic System
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

mGlu2/3 receptor agonist (LY354740) in anxiety

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)

Efficacy and Tolerability of an mGlu2 3 Agonist in the Treatment of Generalized Anxiety Disorder

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

Metabotropic glutamate receptors in the control of mood disorders

Where will new neuroscience therapies come from?

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Translating glutamate: from pathophysiology to treatment

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

Cortical influences of serotonin and glutamate on layer V pyramidal neurons

Metabotropic glutamate receptors, 5 years on

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

Alzheimer's disease research and development: a call for a new research roadmap

Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2− trifluoroethylsulfonyl)pyrid-3-ylmethylamine

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039)

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus

The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats

Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

Suchergebnisse filtern